📈 Price History

Ratio Health

— Excellent

— Good

— Average

— Poor

By Category

📊 Sector Averages

About

UniFirst Corporation provides workplace uniforms and protective work wear clothing in the United States, Europe, and Canada. It operates in three segments: Uniform & Facility Service Solutions; First Aid & Safety Solutions; and Other. The company offers uniforms, including shirts, pants, jackets, coveralls, lab coats, smocks, and aprons; specialized protective wear comprising flame resistant and high visibility garments; and first aid cabinet services and other safety supplies, as well as safety training services. It also engages in the rent and sale of non-garment items and services that include industrial wiping products, floor mats, dry and wet mops, and other textile products, as well as the wholesale distribution and pill packaging operations for non-prescription medicines. In addition, the company provides garment service options, including full-service rental and lease programs. Further, it offers restroom and cleaning supplies, such as air fresheners, paper products, gloves, masks, hand soaps, and sanitizers. Additionally, it provides specialized services, including decontamination and cleaning of work clothes and other items that have been exposed to radioactive materials and services special cleanroom protective wear. The company serves automobile service centers and dealers, delivery services, food and general merchandise retailers, manufacturers, maintenance facilities, restaurants and food-related businesses, business service companies, soft and durable goods wholesalers, transportation companies, energy producing operations, and healthcare providers, as well as others that require employee clothing on the job for image, identification, protection, or utility purposes. UniFirst Corporation was founded in 1936 and is headquartered in Wilmington, Massachusetts.

Key Ratios Snapshot

📈 Growth Pattern

⚡ Latest Quarter —

See full financials →

📊 Quick Scorecard

Loading…

🔍 Concall Decoded

🎙 Management Tone Tracker Confident Specific ~ Volatile 4 quarters analysed

Q2 2025

Confident Specific

Management expressed being 'pleased' with results 'largely in line with expectations' and cited specific improvements in 'merchandise and plant production expenses' and 'operating cash flow up 20.2%'. They also highlighted 'notable improvements in customer retention' and 'solid improvements in operating income and adjusted EBITDA'.

Q3 2025

Cautious

The CEO describes results as 'largely in line with expectations' and notes 'gross margin improvement' but repeatedly highlights headwinds: 'pricing environment that continues to be challenging', 'incremental softness in our customer WERA levels', and the tariff situation as 'fluid' and uncertain. Management emphasizes positive operational execution while tempering top-line enthusiasm.

Q4 2025

Confident Vague

Management expressed confidence in long-term strategy ('laser-focused on driving organic growth') and described fiscal 2025 as 'solid', while using vague language on near-term profitability ('temporary step back') and tariff impacts ('dynamic', 'prudent').

Q1 2026 latest

Confident Specific

Management stated results were 'largely in line with expectations,' reaffirmed full-year guidance with specific revenue ($2.475B-$2.495B) and EPS ($6.58-$6.98) ranges, and gave concrete examples of investments and operational improvements.

Guidance Reliability Pending · <3Q data

Investor Lens

The investment thesis remains largely unchanged after this call. Management reaffirmed guidance and painted a clear path to improved growth and margins through planned investments and technology upgrades, but near-term headwinds from healthcare costs, legal expenses, and a softer employment climate are pressuring margins. The reiteration of confidence in mid-single-digit organic growth and high-teens EBITDA margins over a multi-year horizon suggests the story is intact, though execution risks remain. Key items to watch next quarter are progress in new account installations, retention metrics, the impact of tariffs on costs, and any updates on the Cintas proposal or the timing of margin inflection.

AI-generated concall tone analysis · Updated 2026-06-08 · Not investment advice

🎙 Management Tone Confident Specific ~ Volatile 4 quarters Full tone analysis in Intelligence →

📊 MIXED UniFirst Q1 revenue $621M, EPS $1.89; reaffirms FY guidance

Revenue & Profitability

Consolidated revenue was $621.3 million, up 2.7% YoY from $604.9 million. Operating income was $45.3 million (down from $55.5 million), net income $34.4 million ($1.89 per diluted share) versus $43.1 million ($2.31). Adjusted EBITDA was $82.8 million (down from $94 million). The effective tax rate was 26.9%, expected to be ~26% for full year.

Outlook

Management noted a softer employment climate tempering growth in rental and direct sale accounts. However, they remain confident in long-term demand for their services, with investments in sales and service teams expected to drive improved performance. Tariffs were flagged as a potential cost structure impact.

Growth Drivers

Key growth drivers include strong new account sales, improved customer retention, and additional product placements within existing customers. The First Aid van business is growing double-digits. Investments in a tiered sales organization are targeting mid-size accounts. Organic growth in the core segment was 2.4%, with expectations to move toward mid-single-digit over time.

Balance Sheet & CapEx

Capital expenditures in Q1 were $38.9 million. The company is investing in its ERP project (expected to be largely completed by 2027), digital transformation, and supply chain enhancements. Approximately $7 million of key initiative costs are expected to be expensed in fiscal 2026. Acquisitions included four first-aid businesses for $14.9 million.

Margins

Operating margin for the Uniform segment was 7.4% (down from 8.8%), impacted by planned investments and higher healthcare claims and legal costs. Adjusted EBITDA margin for that segment was 13.6% (down from 15.4%). First Aid segment had a nominal operating loss due to growth investments. Management expects margins to improve as investments yield growth and operating leverage.

Key Risks

Risks cited include higher-than-anticipated healthcare claims and legal costs (impacting Q1), softer employment climate affecting rental and direct sales, and potential tariffs on cost structure. Additionally, the company's ERP and digital transformation projects carry execution risk, and the Cintas proposal introduces uncertainty.

Generated by AI · Q1 2026 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q1 2026 Q1 2026 2026-01-07

Revenue grew 2.7% year-over-year to $621.3M, but operating income and Adjusted EBITDA declined due to planned investments and higher costs. Guidance for 2026 is reaffirmed, with ongoing ERP implementation and strategic investments expected to drive future margin improvement.

Q4 2025 Q4 2025 2025-10-22

Fiscal 2025 saw modest revenue growth and improved customer retention, with ongoing investments in sales, service, and technology expected to drive future gains. Fiscal 2026 guidance anticipates continued revenue growth but lower margins due to tariffs and strategic investments.

Q3 2025 Q3 2025 2025-07-02

Third quarter revenue grew 1.2% year-over-year to $610.8 million, with net income and EPS up, but operating income slightly down. Guidance for annual revenue is unchanged, while EPS guidance is raised due to lower initiative costs. Customer caution and tariff uncertainty persist.

Q2 2025 Q2 2025 2025-04-02

Q2 revenue grew 1.9% to $602.2M, with operating income up 11.7% and net income at $24.5M. Fiscal 2025 EPS guidance was raised to $7.30–$7.70, driven by improved core laundry margins. Customer retention and operational execution showed notable improvement.

Q1 2025 Q1 2025 2025-01-08

First quarter fiscal 2025 results showed modest revenue growth, improved margins, and strong cash flow, despite a challenging pricing and retention environment. The board rejected Cintas's acquisition offer, citing confidence in long-term growth and ongoing investments in technology and operations.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.